...
首页> 外文期刊>Retina >COMBINED INTRAVITREAL RANIBIZUMAB AND ORAL SUPPLEMENTATION WITH DOCOSAHEXAENOIC ACID AND ANTIOXIDANTS FOR DIABETIC MACULAR EDEMA Two-Year Randomized Single-Blind Controlled Trial Results
【24h】

COMBINED INTRAVITREAL RANIBIZUMAB AND ORAL SUPPLEMENTATION WITH DOCOSAHEXAENOIC ACID AND ANTIOXIDANTS FOR DIABETIC MACULAR EDEMA Two-Year Randomized Single-Blind Controlled Trial Results

机译:玻璃体内植物Ranibizumab和口服补充剂与二十二年六六烯酸和抗氧化剂进行糖尿病黄斑水肿两年随机单盲对照试验结果

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: To assess the 2-year effectiveness of intravitreal ranibizumab combined with a dietary supplement rich in docosahexaenoic acid (DHA) plus antioxidants in 62 patients with diabetic macular edema.
机译:目的:评估玻璃体内Ranibizumab的2年效果相结合富含Docosahexonoider(DHA)加抗氧化剂的膳食补充剂在62例糖尿病黄斑水肿中的抗氧化剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号